Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001663577-24-000294
Filing Date
2024-11-19
Accepted
2024-11-19 10:32:25
Documents
48
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q skvi10q3_093024.htm   iXBRL 10-Q 555664
2 GRAPHIC image_001.jpg GRAPHIC 8053
3 GRAPHIC image_002.jpg GRAPHIC 8465
4 ex31_1.htm EX-31.1 9080
5 ex31_2.htm EX-31.2 9000
6 ex32_1.htm EX-32.1 4131
  Complete submission text file 0001663577-24-000294.txt   2591047

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE skvi-20240930.xsd EX-101.SCH 20871
8 XBRL CALCULATION FILE skvi-20240930_cal.xml EX-101.CAL 33289
9 XBRL DEFINITION FILE skvi-20240930_def.xml EX-101.DEF 52030
10 XBRL LABEL FILE skvi-20240930_lab.xml EX-101.LAB 157275
11 XBRL PRESENTATION FILE skvi-20240930_pre.xml EX-101.PRE 129479
51 EXTRACTED XBRL INSTANCE DOCUMENT skvi10q3_093024_htm.xml XML 244271
Mailing Address 6320 S SANDHILL ROAD UNIT 9 LAS VEGAS NV 89120
Business Address 6320 S SANDHILL ROAD UNIT 9 LAS VEGAS NV 89120 702-433-7154
SKINVISIBLE, INC. (Filer) CIK: 0001085277 (see all company filings)

EIN.: 880344219 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-25911 | Film No.: 241473778
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)